Form 8-K - Current report:
SEC Accession No. 0001193125-22-046614
Filing Date
2022-02-18
Accepted
2022-02-18 16:16:09
Documents
12
Period of Report
2022-02-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d319094d8k.htm   iXBRL 8-K 23597
  Complete submission text file 0001193125-22-046614.txt   145087

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220216.xsd EX-101.SCH 2894
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220216_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220216_pre.xml EX-101.PRE 11287
6 EXTRACTED XBRL INSTANCE DOCUMENT d319094d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 22652953
SIC: 2834 Pharmaceutical Preparations